PARP-1 activation and SIRT1 downregulation are important players in the inflammatory processes of many pulmonary diseases such as COPD, asthma, and some viral infections and have now been described in SARS-CoV-2 [78,79,80,81,82]. This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.